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Pseudomonas aeruginosa is a ubiquitous environmental bacterium
capable of causing a variety of life-threatening human infections.
The genetic basis for preferential infection of certain immunocom-
promised patients or individuals with cystic fibrosis by P. aerugi-
nosa is not understood. To establish whether variation in the
genomic repertoire of P. aeruginosa strains can be associated with
a particular type of infection, we used a whole-genome DNA
microarray to determine the genome content of 18 strains isolated
from the most common human infections and environmental
sources. A remarkable conservation of genes including those en-
coding nearly all known virulence factors was observed. Phyloge-
netic analysis of strain-specific genes revealed no correlation be-
tween genome content and infection type. Clusters of strain-
specific genes in the P. aeruginosa genome, termed variable
segments, appear to be preferential sites for the integration of
novel genetic material. A specialized cloning vector was developed
for capture and analysis of these genomic segments. With this
capture system a site associated with the strain-specific ExoU
cytotoxin-encoding gene was interrogated and an 80-kb genomic
island carrying exoU was identified. These studies demonstrate
that P. aeruginosa strains possess a highly conserved genome that
encodes genes important for survival in numerous environments
and allows it to cause a variety of human infections. The acquisition
of novel genetic material, such as the exoU genomic island,
through horizontal gene transfer may enhance colonization and
survival in different host environments.
Members of the genus Pseudomonas are some of the mostdiverse bacterial species in the environment. Particularly
important are Pseudomonas aeruginosa, which are commonly
encountered aerobic microbes that have evolved the remarkable
capacity to inhabit diverse natural environments and infect
higher organisms such as insects, plants, and animals (1). In
humans, P. aeruginosa can colonize virtually any mucosal surface
and invade tissues and blood (2). Its ability to thrive in a broad
range of environments is in part caused by the fact that it
possesses a large and diverse genome (3). Furthermore, P.
aeruginosa possesses the largest proportion of regulatory genes
(1 in 10) of all of the sequenced bacterial genomes (3). This
striking feature likely provides a means for coordinating the
expression of its many genes in response to a wide range of
environmental demands.
Comparative genomics based on the analysis of complete
genomes of different strains of the same species can provide
valuable insights into the acquisition or loss of genes through
horizontal gene transfer and evolution of genes through changes
at the nucleotide sequence level. With the availability of DNA
microarrays, a larger number of genomes can be compared (4).
When representative subsets of strains are examined, useful
evolutionary questions can be answered by genome content
analysis. Particularly informative have been those studies that
used genomic microarray hybridization technology to investigate
the epidemiology of disease and correlate the loss of genes with
changes in virulence. Specifically, microarray analysis has been
used to demonstrate a correlation between certain genes in
Vibrio cholerae and specific pandemics (5). In addition, a mi-
croarray hybridization-based study of Staphylococcus aureus
variants associated with toxic shock syndrome and methicillin
resistance revealed that these strains evolved in parallel with
changing conditions in the host environment and antibiotic
treatment (6). The same approach was used to demonstrate the
genetic basis for attenuation of virulence in strains of Mycobac-
terium tuberculosis including those used for vaccination (7).
Analysis of Helicobacter pylori genomes from a wide range of
strains has resulted in the identification of a limited number of
variable chromosomal segments and their association with spe-
cific virulence factors (8). Further studies of this organism have
provided evidence for the evolution of the genome of individ-
ual clones (including deletions of genes) in a highly restricted
niche (9).
To correlate the genome content of P. aeruginosa strains with
the various niches that it can inhabit and the different diseases
that it can cause, we assembled a collection of strains and
assessed their genomic repertoire by using a whole-genome
DNA microarray. We have shown that the genome of this
organism is highly conserved and that there exists a core set of
genes, including nearly all known virulence factors, which are
present in all strains regardless of disease source. Interestingly,
the same genes are conserved among environmental isolates. We
further developed a general strategy, including a specialized
cloning vector, for the interrogation of chromosomal regions that
show a high degree of polymorphism and often serve as sites of
large deletions and insertions. The approach of combining
microarray hybridization analysis and targeted capture of iden-
tified variable chromosomal segments should facilitate the anal-
ysis of many variants of a single species without the need for
large-scale sequencing of entire genomes.
Materials and Methods
Genome Content Analysis. GeneChip P. aeruginosa Genome Ar-
rays (Affymetrix) were used to assess genome content. Chro-
mosomal DNA hybridizations were performed as described (10).
Hybridization intensity data were extracted from the scanned
array images, and intrachip normalizations were performed by
using Affymetrix MICROARRAY SUITE 5.0 software. The average
signal intensity of the probe sets was scaled to 500 for interchip
comparisons. A presenceabsence determination was made by
comparing hybridization signal between strains. Values derived
from the PAO1 genomic DNA hybridization were used as
baseline. Probe sets with a ratio of 0.25 were considered
present (blue). Ratios between 0.1 and 0.25 were considered
indeterminate (gray), and ratios 0.1 were designated absent
(yellow).
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Design and Construction of a Multifunctional Yeast Capture Vector. A
detailed description of the construction of the yeast capture
vector p0975–0989capture is provided in Supporting Materials
and Methods, which is published as supporting information on
the PNAS web site, www.pnas.org.
Recombinational Cloning. The variable genomic segments of P.
aeruginosa strains PAO1, PAK, CF127, 6077, and JJ692, f lanked
by conserved genes PA0975 and PA0989, were cloned by co-
transforming 200 l of competent Saccharomyces cerevisiae
strain CRY1–2 spheroplasts with 10 g of unsheared chromo-
somal DNA and 1 g of MluI-linearized plasmid p0975–
0989capture. Competent spheroplasts were prepared as de-
scribed with the exception of using 10 units of Zymolyase 20T
(ICN) instead of lyticase and 10 mM DTT instead of 2-mercap-
toethanol (11). Transformation mixtures were plated on uracil-
deficient media containing cycloheximide (2.5 gml).
Selection of Recombinant Clones. S. cerevisiae colonies were
screened by PCR for the presence of captured P. aeruginosa
sequences. A portion of each colony was suspended in 15 l of
zymolyase buffer (10 mM sodium phosphate buffer, pH 7.51 M
sorbitol2.5 mg/ml zymolyase 20T) and incubated with shaking
for 1 h at 37°C. Two microliters of suspension was used as
template for each PCR. Primers used to detect an insert were
5-GGCTCGACCTCAATGGCATGGGCG and 5-TCA-
GAAATATGGCGTCGGGTCGGA, which amplified a 500-bp
portion of PA0976 that is not included in the original vector but
is predicted to be present in the captured sequences. Plasmid
DNA from yeast colonies that produced a PCR product of the
correct size was purified and electrotransformed into Escherichia
coli Genehogs (Invitrogen) for subsequent analysis.
Results and Discussion
Strain Variability and Genome Conservation. We have examined the
genome composition of a collection of 18 P. aeruginosa strains by
using a whole-genome DNA microarray consisting of probes for
5,549 nonredundant genes that constitute the genome of the
sequenced strain PAO1 (3). The collection included four envi-
ronmental isolates, a laboratory strain, and strains isolated from
the most common human infections, including four respiratory
isolates from children (24 months) with cystic fibrosis, five
strains associated with urinary tract infections, and two isolates
each from ocular and blood infections (Table 1, which is
published as supporting information on the PNAS web site). Fig.
1 indicates the predicted presence or absence of each PAO1 gene
in the interrogated strains, organized relative to their chromo-
somal location in the reference PAO1 genome. The presence or
absence of these genes was predicted based on the relative
hybridization of chromosomal DNA to the microarray (see
Materials and Methods). Detailed results for each gene are
provided in Table 2, which is published as supporting informa-
tion on the PNAS web site.
The fraction of PAO1 genes detected in the various strains
ranged from 96.1% to 97.7% (Fig. 4, which is published as
Fig. 1. Analysis of genome content indicates a high level of gene conserva-
tion. The diagram indicates the presence and absence of genes found in the
sequenced genome of strain PAO1 in clinical and environmental isolates of P.
aeruginosa as detected by microarray hybridization. Strains are indicated at
the top. The source of each strain is as follows: PAO1, reference strain; PAK,
laboratory strain; environmental isolates (62, E2, MSH3, MSH10); respiratory
isolates from children (24 months) with cystic fibrosis (CF127, CF18, CF27,
CF5); isolates from urinary tract infections (X24509, UDL, S54485, JJ692,
U2504); strains isolated from ocular infections (19660, 6077), and blood iso-
lates (S35004, X13273). Horizontal lines represent genes. Blue indicates that a
gene is present, yellow represents absence, and gray indicates that presence
was indeterminate. Red lines represent the location of tRNA genes in strain
PAO1. The scale represents 5,613 genes (including 5,549 ORFs and 64 tRNA-
encoding genes) organized according to the PAO1 chromosome. Green circles
indicate variable segments in the P. aeruginosa genome as discussed in the
text. Red triangles indicate known sites of insertion of horizontally acquired
genetic material. References are indicated in parentheses.































supporting information on the PNAS web site), with 5,183
(93.4%) of the 5,549 PA01 genes present in all strains tested.
These 5,183 genes represent the core set of genes, presumably
encoding proteins that function in the diverse range of environ-
ments that this organism can inhabit. This finding represents a
conservative estimate because our analysis does not compensate
for sequence polymorphisms or strain-specific genes (see below)
that are unrelated at the nucleotide sequence level but encode
proteins with conserved function.
The distribution of core genes based on functional classifica-
tion relative to the PAO1 genome (annotation tables available at
www.Pseudomonas.com) indicates a broad conservation of func-
tional diversity (Fig. 5, which is published as supporting infor-
mation on the PNAS web site). The only functional class of genes
that showed significant underrepresentation in all strains in-
cluded genes associated with horizontal gene transfer (classified
as related to phage, transposon, or plasmid). Only 8.6% of these
genes were conserved in all strains examined. Of the 53 variable
genes in this category 42 constitute two cryptic prophages
identified in strain PAO1 but not found in most of the examined
strains (Fig. 1, segments 3 and 4) (3).
Of particular interest are those genes associated with P.
aeruginosa virulence. These genes are almost exclusively found
in the category called secreted factors. Additional genes related
to the expression of virulence determinants are found in the
categories motility and attachment, protein secretionexport
apparatus, and transcriptional regulators. Examination of the
genes that play a direct role or are predicted to play a direct role
in virulence (267 genes; Table 3, which is published as supporting
information on the PNAS web site) indicates a high level of
conservation (97%). The extensive conservation of virulence
genes in the genomes of strains regardless of their clinical source
suggests that the disease-causing ability of this opportunistic
pathogen during human infections relies, in general, on a set of
highly conserved pathogenic mechanisms. However, specific
features of each disease may be influenced by phenotypic
characteristics provided by individual or a small number of
strain-specific virulence genes (for example, exoU and exoS, see
below). The conservation of virulence determinants also extends
to environmental isolates, suggesting that selection for the
maintenance of such traits exists in the environmental reservoir.
Based on this conservation it is likely that the environmental
strains studied possess the ability to cause human infections
despite the low probability of encountering a human host.
The 368 genes that are absent from the genome of at least one
strain can be considered strain specific (Table 4, which is
published as supporting information on the PNAS web site). This
set of genes was subjected to a phylogenic analysis, which shows
that strains from similar environmental or clinical sources are in
general no more related than those from different sources (Fig.
2A). Not surprisingly, the most closely related strains are the only
two isolates from the same locale, the two environmental strains
isolated from Spirit Lake, Washington (MSH3 and MSH10).
These strains were selected from a larger collection based on
unique colony appearance and differential sensitivity to the
pilus-specific phage PO4. The second most highly related strains
are a pair of clinical isolates from a cystic fibrosis patient and a
blood infection (strains CF127 and S35004, respectively) col-
lected at hospitals in different cities (Table 1). Perhaps the most
interesting relationship is demonstrated by a group of five
strains, three of which were isolated from urinary tract infections
(S54485, JJ692, and U2504), one from an ocular infection (6077),
and the last from a blood infection (X13273). These strains share
several epidemiological markers including the presence of genes
for the O11-serotype capsular polysaccharide (data not shown).
In addition, these strains are characterized by the presence of the
exoU gene and its cognate chaperone spcU in their genomes (Fig.
2B). ExoU is a cytotoxin secreted by the type III secretion system
of P. aeruginosa (13). Its expression is associated with increased
virulence in model infection systems and poor clinical prognosis
in patients (14, 15). A relationship between ExoU-expressing
strains has been previously recognized among ocular isolates
based on the coincidence of exoU with several phenotypic and
genetic traits (16). It is apparent from our studies that this clonal
relationship, based on gene content, includes isolates from a
wider range of disease states. Another ocular isolate (19660) also
carries the exoU and spcU genes; however, it is phylogenetically
unrelated to the rest of the strains in this survey. It was previously
reported that carriage of exoU is accompanied by the absence of
exoS, which encodes another type III secreted protein (17, 18).
We also found that the six strains, in this study, with exoU in their
genome all lacked exoS (Fig. 2B). The relative conservation of
the genomes of these strains, including the exoU carriage and
deletion of exoS (see below), implies that conserved selective
pressures contributed to the evolution of these genomes in
different environmental niches. What selective advantage arises
from mutual exclusion of one of two genes encoding virulence
factors with distinct activities is unclear. Because the host cell
contact-dependent type III secretion system secretes both ExoU
and ExoS, the advantage afforded by expression of either one of
these genes almost certainly involves interaction with a target
eukaryotic organism.
Distribution and Pattern of Strain-Specific Genes Relative to the
Reference Genome. Distinct patterns of variability were evident
when the genomes of multiple strains were compared (Fig. 1).
Strain-specific genes were localized to 90 discrete regions rela-
tive to the PAO1 genome (Table 2). Many of these regions are
composed of small gene blocks (one to four genes) that showed
variability in one or more strains. These variable blocks likely
contain genes that are highly polymorphic at the nucleotide
sequence level or are gained or lost through local recombination
events (see below).
A second pattern, which is more readily apparent, is charac-
terized by large clusters of tandem genes that show varying levels
of polymorphism between strains. Twenty-four of these regions
(termed variable segments) were identified (Fig. 1, Table 2).
These variable segments are scattered throughout the genome;
however, a significant number are immediately adjacent to
Fig. 2. Phylogenetic analysis of P. aeruginosa isolates based on genome
content indicates a limited clonal relationship but no correlation with disease.
(A) Dendrogram showing the relationship between strains based on the
presence and absence of genes designated as strain specific. The source of
each strain is indicated. Analysis was performed by using a previously de-
scribed algorithm for the hierarchical clustering of microarray hybridization
data (12). (B) Correlation between a group of clonally related strains and
the presence of certain strain-specific virulence genes. The presence (blue)
and absence (yellow) of genes encoding ExoU, SpcU, and ExoS are indi-
cated. Strains are arranged according to their position in the accompanying
dendrogram.























tRNA or tmRNA genes (Fig. 1, segments 2, 4–6, 16–19, and 24).
The use of these genes as targeting sites for the integration of
mobile genetic elements is well documented (19). In fact, four
different P. aeruginosa tRNA genes have been previously shown
to act as integration sites for bacteriophage, plasmids, and
genomic islands (19–23) (Fig. 1). A number of additional
genomic islands identified in P. aeruginosa are not directly
associated with tRNA genes but do localize to regions of the
chromosomal that show a high degree of variability (24–26) (Fig.
1). Based on the association of known genomic islands and other
horizontally transferred genetic elements with regions of vari-
ability, we predict that the variable segments identified here
may represent additional sites for integration of novel genetic
material.
Deviation in the percentage (GC) content of genes from that
of the genome average is another marker of horizontal gene
transfer. Annotation of the sequenced PAO1 genome revealed
10 such regions (3). With the exception of a cluster of low
percentage (GC) content genes encoding ribosomal proteins,
all were associated with regions of P. aeruginosa genomes that
contain strain-specific genes (Table 2). In fact, strain-specific
genes as a group (Table 4) have an average percentage (GC)
of 61.8%, which is significantly lower than the average for core
genes (67.1%). This finding suggests that many of these genes are
associated with recently acquired genetic material.
Interrogation of Strain-Specific Genes. An ‘‘absent’’ call based on
the microarray hybridization results suggests that the particular
locus in the test strain, relative to PAO1, either lacks the
corresponding gene altogether (deletion) or it contains a gene or
genes that significantly differ from that in the reference strain.
To investigate several such loci we designed oligonucleotides that
corresponded to conserved flanking genes and used them to
prime PCRs such that the resulting amplification products would
span the polymorphic regions. Sequence and size analysis of the
products allowed us to delineate whether an undetected gene
had been deleted or replaced by a small insertion. Two such
examples involving genes encoding proteins secreted by the type
III secretion system are presented. The example in Fig. 3A shows
that the exoY gene (PA2191), encoding a secreted adenylate
cyclase (27), is f lanked in PAO1 by two ORFs (PA2190 and
PA2192) that encode conserved hypothetical proteins. These
two flanking genes are absent from the chromosome of four
isolates (PAK, CF27, S54485, and X13273). Six strains (CF127,
CF5, JJ692, U2504, 6077, and S35004) lack only PA2190. Finally,
one of the strains (19660) lacks all three genes (PA2190, exoY,
and PA2192). Sequence analysis allowed us to identify the
Fig. 3. Analysis of polymorphic genes and variable segments associated with
type III secreted effector-encoding genes. (A) Loss of genes in the flanking
region of exoY. (Top) Diagram showing the presence (blue) and absence
(yellow) of exoY and flanking genes in the indicated strains. (Middle) Sum-
mary of the specific deletioninsertion events detected by PCR analysis. Not
shown is the deletion of all three genes in strain 19660. (Bottom) Sequence
analysis of the exoY flanking regions indicates the specific deletioninsertion
junctions for strains PAK, CF127, CF27, CF5, S54485, JJ692, U2504, 6077,
S35004, and X13273. Sequences in bolditalics are absent in the corresponding
deletion strains indicated as yellow (Top). Coordinates of the junction sites
relative to the PAO1 chromosome are given. (B) Diagram showing a variable
segment of P. aeruginosa genomes associated with the acquisition of exoU.
Blue boxes indicate the presence of PAO1 genes in the interrogated strains.
Yellow indicates undetected genes, and gray represents genes for which no
definitive determination could be made. Red boxes show the location of an
intact tRNAlys gene and a partial duplication of the same gene in the PAO1
genome. Black bars indicate the location of conserved targeting sequences
(TS1 and TS2) used in the construction of the capture vector. (C) Size deter-
mination of captured sequences between conserved genes PA0975 and
PA0989 in five P. aeruginosa strains. DNA fragments were analyzed on a 1%
agarose gel by pulsed-field gel electrophoresis using the Bio-Rad Chef Mapper
System. Lane M1, 1-kb DNA ladder (Invitrogen); lane M2, Midrange I PFG
Marker (New England Biolabs). Subsequent lanes contain plasmids with cap-
tured sequences from the indicated strains. Inserts were separated from the
vector (indicated by *) by digestion with I-SceI. Lane 1, PAO1; lane 2, PAK; lane
3, CF127; lane 4, 6077; lane 5, JJ692. (D) Restriction fragment fingerprinting of
captured sequences. Lane M, 1-kb DNA ladder. The following lanes contain
NcoI digested plasmids with captured sequences from the indicated strains: 1,
PAO1; 2, PAK; 3, CF127; 4, 6077; and 5, JJ692. Asterisks denote the location of
vector fragments.































precise site of deletion or insertion in each case relative to the
PAO1 genome (Fig. 3A).
A similar analysis of the exoS region confirmed that a number
of strains lack this particular gene (Fig. 2B and Fig. 6, which is
published as supporting information on the PNAS web site). In
the PAO1 genome exoS is f lanked by a near perfect (9 of 10 bp)
direct repeat (Fig. 6). Sequence analysis indicates that a recom-
bination event between these repeats could account for the loss
of exoS in strains S54485, JJ692, U2504, 19660, 6077, and
X13273. In all cases the adjacent gene (orf1) is unaffected (Fig.
6). Interestingly, orf1 encodes a specific chaperone essential for
ExoS secretion from P. aeruginosa by the type III secretion
system (28). It is therefore likely that the absence of exoS is the
result of a specific deletion event. Given that nearly all strains
that lack exoS contain exoU (Fig. 2B) it is conceivable that
acquisition of exoU leads to the deletion of exoS by an unknown
mechanism.
Interrogation of Variable Segments in the Genomes of P. aeruginosa
by Recombinational Cloning. The inability to span a region iden-
tified as absent by PCR may indicate the presence of a large
insertion. Clusters of unique genes at a particular location in the
genome called ‘‘genomic islands’’ are not uncommon. As de-
scribed above, microarray analysis can be used to identify
preferential sites of integration of such islands. We constructed
a capture vector for yeast recombinational cloning of genomic
islands. The vector is a modified version of the plasmid used for
cloning P. aeruginosa LPS islands (26). It includes several
features that will greatly facilitate the analysis of bacterial
genomes and simultaneously provide a tool for further down-
stream functional studies of the genes within the genomic
islands. The salient features of the vector are outlined in Fig. 7,
which is published as supporting information on the PNAS web
site. PCR amplification of regions flanking a variable chromo-
somal segment results in two targeting sequences that are cloned
into the capture vector to provide specificity. After cotransfor-
mation of competent S. cerevisiae with P. aeruginosa chromo-
somal DNA and the capture vector, recombination mediated by
endogenous yeast proteins facilitates cloning of the P. aeruginosa
chromosomal DNA flanked by the homologous targeting se-
quences. The captured chromosomal DNA is bordered by a short
sequence specifying the recognition site for the I-SceI restriction
endonuclease. Because this sequence is absent from the P.
aeruginosa genome (and from the sequenced genomes of most
bacteria) it can be used in preliminary estimation of the size of
the insert.
A single capture vector can be constructed and used to
interrogate the same region in a large number of strains. The
captured sequences can be mobilized into any recipient P.
aeruginosa strain by conjugation. Transfer of the captured island
into a recipient strain lacking the equivalent sequences will allow
for functional assessment. After targeted disruption of a partic-
ular gene or transposon mutagenesis of the entire segment, the
inactivated gene(s) can be readily introduced onto the P. aerugi-
nosa chromosome by allelic exchange using the method of SCE
jumping (29).
We used this vector to investigate whether acquisition of exoU
and its linked chaperone spcU involves integration of a genomic
island into a common locus in the P. aeruginosa chromosome.
The published sequence of exoU from strain PA103 (GenBank
accession no. AF027291) (30) contained a segment 3 of the
spcU-coding sequence that was nearly identical to the position
1,069,669–1,069,934 bp of the P. aeruginosa strain PAO1 chro-
mosome. This segment is located in a highly polymorphic region
of the chromosome (Fig. 1, segment 6). Closer examination
reveals that this variable segment (encompassing genes PA0977–
PA0987) is f lanked by highly conserved genes (Fig. 3B). To
interrogate this region of the chromosome in different P. aerugi-
nosa strains we designed a capture vector that included targeting
sequences derived from the conserved flanking genes (Fig. 3B).
As a control we cotransformed competent yeast with the capture
vector and chromosomal DNA from strain PAO1. The resulting
clone was analyzed by digestion with I-SceI, which released a
12-kb fragment from the capture vector, corresponding to the
predicted size of the PAO1 sequence (Fig. 3C, lane 1). Restric-
tion fragment fingerprinting of the cloned insert with the NcoI
restriction endonuclease generated fragments that agreed with
the predicted location of NcoI recognition sites in this region of
the PAO1 chromosome (Fig. 3D, lane 1). Chromosomal DNA
from four additional strains was captured and the recovered
plasmids were analyzed as above (Fig. 3 C and D). Two exoU-
carrying strains (6077 and JJ692) possessed a large insert of 80
kb (Fig. 3C, lanes 4 and 5). The NcoI digestion patterns
confirmed that these inserts are very similar or perhaps even
identical (Fig. 3D, lanes 4 and 5). PCR analysis confirmed that
they indeed carried the exoU and spcU genes (data not shown).
Analysis of sequences captured from strains lacking exoU (PAK
and CF127) indicated that these strains each carried a different-
sized chromosomal segment (7 and 3 kb, respectively; Fig. 3C,
lanes 2 and 3). The NcoI restriction pattern for these segments
suggests that they may have arisen through the deletion of
sequences from the larger PAO1 sequence. Because a tRNA
gene flanks this region, integration of the acquired DNA in the
exoU-carrying strains may involve a site-specific recombination
system (19). Interestingly, this locus has been previously de-
scribed as one of two sites for semistable incorporation of a large
plasmid present in many genomes of European isolates of P.
aeruginosa (22). Collectively, these data indicate that this region
of the P. aeruginosa chromosome may be a ‘‘hotspot’’ for
integration of horizontally acquired DNA.
Conclusion
The work presented here shows that the genomes of P. aerugi-
nosa strains, representing distinct clinical or environmental
sources, are highly conserved. These results support a basic
model whereby conservation of a large genome allows this
organism to inhabit the widest possible range of environments
and confers the ability to cause human infections after relatively
infrequent encounters. Although we cannot predict the total
gene content of individual strains or whether detected genes are
functional, the remarkable conservation of genes encoding
proteins associated with virulence indicates that most strains,
regardless of source, possess the basic pathogenic mechanisms
necessary to cause a wide variety of human infections. The fact
that this conservation extends to environmental strains indicates
the existence of a natural environmental eukaryotic host and
further suggests that environmental strains of P. aeruginosa can
serve as the source for human infections.
Analysis of the microarray hybridization patterns revealed a
number of variable segments in the P. aeruginosa genome that
may serve as sites of integration of horizontally transferred
genetic material. Given the limitations of the microarray hybrid-
ization technique we cannot determine which of these sites are
occupied or the nature of the acquired sequences. To investigate
these sites we developed a multifunctional capture vector and
used it to identify an 80-kb genomic island carrying a known
virulence gene (exoU). This approach will be useful for identi-
fying additional virulence genes that may enhance the ability of
P. aeruginosa to survive in specific host niches; however, we
expect this number to be small, as extensive work over the past
25 years using a variety of clinical isolates has led to the discovery
of very few virulence genes that are not part of the core set
present in nearly every P. aeruginosa strain analyzed.
Our study demonstrates the power of whole genome-based
microarrays to analyze genome evolution, based on the gene
content relative to a reference strain. We further developed a























useful tool for the isolation and interrogation of strain-specific
islands in bacterial genomes. When these technologies are
combined, they should provide essential tools for large-scale
analysis of bacterial populations and lead to a better under-
standing of the selective pressures that control genome mainte-
nance and the spread of novel genetic material.
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